Head and neck cancer: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• PD-1 69
• PD-L1 42
• TP53 7
• EGFR 33
• PI3K 6
• STAT3 1
• BRAF 0
• AKT 2
• mTOR 0
• HER2 6
• RET 0
• MAPK 0
• ERK 0
• STING 0
• PTEN 1
• TERT 0
• CTNNB1 0
• JAK 1
• CTLA-4 4
• NRF2 0
• VEGF 4
• MYC 0
• YAP 1
• MET 3
• CLDN18 0
• HIF-1 0
• IL-6 2
• JNK 0
• AMPK 0
• PARP 1
• FGFR 1
• B7-H3 5
• COX-2 0
• GPX4 0
• LAG-3 2
• TROP2 5
• EZH2 0
• MEK 0
• CD47 1
• METTL3 0
• PIK3CA 4
• CDK4/6 2
• NLRP3 0
• ATM 0
• PKM2 0
• TNF 0
• FAK 0
• MMP-9 0
• PPAR 0
• PSMA 1
• TLR4 0
• BCL-2 0
• HSP90 0
• KRAS 0
• NOTCH1 0
• NTRK 1
• ALK 0
• CD40 1
• CXCR4 0
• HER3 4

EU-13 is a filter, not a ranking: it only narrows the list.

3 of 3+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Trials whose registry record says individual participant data (IPD) will be shared.

• Induction and Maintenance Treatment With PARP Inhibitor and Immunotherapy in HPV-negative HNSCC

  NCT04681469· Gruppo Oncologico del Nord-Ovest· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 84
• Organoids 23
• Mendelian Randomization Analysis 49
• CRISPR-Cas Systems 13
• Gene Expression Profiling 241
• Sequence Analysis, RNA 26
• Whole Genome Sequencing 6
• Exome Sequencing 22
• Proteomics 64
• Metabolomics 43
• Mass Spectrometry 14
• Flow Cytometry 56
• Immunohistochemistry 330
• Liquid Biopsy 33
• Circulating Tumor DNA 56
• Xenograft Model Antitumor Assays 305
• Positron-Emission Tomography 83
• Magnetic Resonance Imaging 272
• Machine Learning 232
• Deep Learning 186
• Cohort Studies 294
• Genome-Wide Association Study 55

• Health-related quality of life as a complementary prognostic marker in nasopharyngeal carcinoma: an explainable machine-learning survival analysis.

  Qual Life Res, Nov 2026

• AI-driven infrared spectroscopy in salivary oral leukoplakia.

  Clin Oral Investig, Nov 2026

• Explainable computational framework for subtype classification and biomarker identification in head and neck squamous cell carcinoma using machine learning.

  PLoS One, Nov 2026

• Early vs late fusion of qMIDS with machine learning based classifiers for oral cancer diagnosis from gene expression data.

  PLoS Comput Biol, Oct 2026

• Incorporating natural language processing-derived features from pathology reports into machine learning models to predict differentiated thyroid cancer recurrence.

  Front Endocrinol (Lausanne), Oct 2026

• Network pharmacology and machine learning reveal kit as a target of roburic acid in anaplastic thyroid carcinoma: Preliminary in vitro validation.

  PLoS One, Oct 2026

• Detection of Cervical Nodal Metastasis in Oral Squamous Cell Carcinoma Using Elastic Scattering Spectroscopy: Ex Vivo Diagnostic Modeling Study.

  JMIR Cancer, Oct 2026

• Effectiveness of radiotherapy or chemoradiotherapy in older patients with advanced-stage, non-surgically treated head and neck cancer: A machine learning analysis.

  Med Oncol, Oct 2026

• A genetic algorithm-optimized EWMA control chart integrating machine learning-based risk prediction for multistage thyroid cancer treatment monitoring.

  PLoS One, Oct 2026

• An explainable and leakage-aware machine learning model for early risk stratification of radioiodine-refractory differentiated thyroid cancer: development and single-center geographic external validation.

  Front Endocrinol (Lausanne), Oct 2026

See which targets of this disease your abstract mentions, and go to the people working on them.